For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research.
Family history and location of genetic fault affect risk for carriers of key breast and ovarian cancer genes20 Jun 2017
A large scale study of women carrying faults in important cancer genes should enable doctors to provide better advice and counselling for treatments and lifestyle changes aimed at reducing this risk.
Scientists have unearthed crucial new genetic information about how breast cancer develops and the genetic changes which can be linked to survival, according to a study published in Nature Communications today.
An international study of almost 120,000 women has newly identified five genetic variants affecting risk of breast cancer, all of which are believed to influence how breast cells respond to the female sex hormone oestrogen.
A test for a wide range of genetic risk factors could improve doctors’ ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has shown.
Newspaper reports suggest that France may be considering health warnings – or even an outright ban – on breast implants, following a cancer scare. Should women be concerned? Dr Suzanne Turner from the Department of Pathology, University of Cambridge, looks at the truth behind the headlines.
Scientists have discovered 15 previously unknown genetic ‘hot-spots’ that can increase a woman’s risk of developing breast cancer, according to research published today in Nature Genetics.
Breast cancer risks for one of potentially the most important genes associated with breast cancer after the BRCA1/2 genes are today reported in the New England Journal of Medicine. Women with mutations in the PALB2 gene have on average a one in three chance of developing breast cancer by the age of seventy.
Women with breast cancer are 10 per cent more likely to survive for five years or more if they have certain immune cells near their tumour, according to new research.